Bright Minds Biosciences (DRUG) Net Equity Issued and Repurchased (2020 - 2026)
Bright Minds Biosciences' Net Equity Issued and Repurchased came in at $79,233 for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with $6,315 a year earlier and up 155.1% from the prior quarter.
Bright Minds Biosciences (DRUG) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Bright Minds Biosciences reported Net Equity Issued and Repurchased of $227,011, down 65.5% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $959,365.
- Net Equity Issued and Repurchased carries a four-year compound annual growth rate of 87.8% (FY2021 to FY2025).
- Going back by fiscal year, Net Equity Issued and Repurchased was $1.29 million in FY2022 and $77,066 in FY2021.
- The five-year range for quarterly Net Equity Issued and Repurchased is -$189,049 (fiscal Q4 2023) to $1.24 million (fiscal Q4 2022).
- Business Quant data shows DRUG's Net Equity Issued and Repurchased at $31,055 (Q2 2026), $6,275 (Q1 2026) and $110,449 (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Bright Minds Biosciences | 387.06 Mn | 387.06 Mn | - | 79,232.61 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79,232.61 |
| Mar 31, 2026 | 31,055.41 |
| Dec 31, 2025 | 6,274.50 |
| Sep 30, 2025 | 110,448.52 |
| Jun 30, 2025 | 6,314.98 |
| Mar 31, 2025 | 174,238.18 |
| Dec 31, 2024 | 665,801.98 |
| Sep 30, 2023 | -189,048.62 |
| Dec 31, 2022 | 186,709.99 |
| Sep 30, 2022 | 1.24 Mn |
| Mar 31, 2022 | -66,762.78 |
| Dec 31, 2021 | 93,811.99 |
| Sep 30, 2020 | -37,521.18 |
Bright Minds Biosciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=DRUG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "DRUG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=DRUG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();